People: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

2.36USD
23 May 2013
Price Change (% chg)

$0.02 (+0.85%)
Prev Close
$2.34
Open
$2.27
Day's High
$2.39
Day's Low
$2.25
Volume
267,979
Avg. Vol
736,988
52-wk High
$4.50
52-wk Low
$1.06

Search Stocks

Wesson, Bruce 

Brief Biography

Mr. Bruce F. Wesson is an Independent Director of Acura Pharmaceuticals, Inc., since March 1998. From January 1991 until June 30, 2011 Mr. Wesson was a Partner of Galen Associates, a health care venture firm, and a General Partner of Galen Partners III, L.P. Prior to January, 1991, he was Senior Vice President and Managing Director of Smith Barney, Harris Upham & Co. Inc., an investment banking firm. He serves on the Boards of Derma Sciences, Inc., and as Vice Chairman of the Board of MedAssets, Inc., each a publicly traded company. Mr. Wesson earned a Bachelor of Arts degree from Colgate University and a Masters of Business Administration from Columbia University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Robert Jones

602,353

Peter Clemens

340,863

Robert Seiser

267,490

J. Bradley Rivet

352,988

Albert Brzeczko

452,608

James Emigh

267,490
As Of 30 Dec 2012
Search Stocks